Allergy/Asthma News

The respiratory and health impacts of cooking — a ubiquitous household chore often assumed by women — may be underappreciated, with fumes from gas and propane stoves a leading source of asthma, data show.

The Asthma and Allergy Foundation of America, also known as AAFA, released its yearly list of the most difficult cities for people with asthma to live in within the United States.

A common question we receive every 4 years is: How will the election impact my investments?

Do you recall seeing teal pumpkins at various houses around Halloween? Why is this? Why would someone choose teal over orange? Led by Food Allergy Research & Education, it is called the Teal Pumpkin Project.

Patients with severe asthma and small airways disease did not respond as well to omalizumab treatment, according to a poster presented at the European Respiratory Society International Congress.

Healio has compiled September’s most-read news in asthma and allergy.

A three-session rush venom immunotherapy protocol was safe and effective with nearly all patients achieving maintenance dosing with few systemic reactions, according to a study published in Annals of Allergy, Asthma & Immunology.

New interim, long-term results showed that nemolizumab improved signs and symptoms of atopic dermatitis including sleep, itch and quality of life, according to a presentation at the European Academy of Dermatology and Venereology Congress.

Dupilumab was safe and effective in treating a group of six children and young adults with inborn errors of immunity and moderate to severe atopic dermatitis, according to a study published in Pediatric Allergy and Immunology.

Patients infected with SARS-CoV-2 saw a reduction of immune cells and a change in growth factor patterns in their blood 10 months after infection, according to a study published in Allergy.